In Silico Study of Naringenin as Melanogenesis Inducer in Vitiligo
Authors:
Open Access
- 9 January 2023
- journal article
- research article
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 14 (6) , 847-857
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- In-silico screening of inhibitor on protein epidermal growth factor receptor (EGFR)IOP Conference Series: Earth and Environmental Science, 2022
- Emerging drugs for the treatment of vitiligoExpert Opinion on Emerging Drugs, 2020
- Relationships of dietary flavonoid structure with its tyrosinase inhibitory activity and affinityLWT, 2019
- Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunitiesPharmacology & Therapeutics, 2019
- MITF and UV responses in skin: From pigmentation to addictionPigment Cell & Melanoma Research, 2018
- Two new coumarins and a new xanthone from the leaves of Rhizophora mucronataBioorganic & Medicinal Chemistry Letters, 2018
- Wnt/β-catenin signaling pathway activates melanocyte stem cells in vitro and in vivoJournal of Dermatological Science, 2016
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based SignaturesJournal of Medicinal Chemistry, 2015
- Transcriptional Profiling Shows Altered Expression of Wnt Pathway– and Lipid Metabolism–Related Genes as Well as Melanogenesis-Related Genes in MelasmaJournal of Investigative Dermatology, 2011
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001